Prospective Study on Intensive Early Rheumatoid Arthritis Treatment
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Early intensive treatment with anti-TNF agent plus methotrexate plus high dose
prednisone may increase remission rate and may induce stable remission in Rheumatoid
Arthritis Objective: to evaluate induction of remission using adalimumab, prednisone and
methotrexate and maintenance of remission after discontinuation of adalimumab and prednisone